Zifivax Vaccine to Undergo Mass Production Phase
PT Biotis Pharmaceutical Indonesia (Biotis) and PT Jakarta Biopharmaceutical Industry (JBio) are producing Zifivax or Anhui vaccine developed by a Chinese company, Anhui Zhifei Longcom Biopharmaceutical. Biotis President Director FX Sudirman revealed that the vaccine would be mass-produced at the factory located in Gunung Sindur, Bogor Regency, West Java.
He said that the fill and finish capacity of the Biotis factory could actually reach 20 million doses of vaccine per month. But the company plans to only produce 10 million doses in November and December so that by the end of 2021, 20 million doses will be available. "Actually, our factory is capable of producing 20 million vaccines per month. However, in the near future, we plan to also produce the Merah Putih Vaccine," Sudirman explained on Tuesday.